General
Preferred name
REBAUDIOSIDE A
Synonyms
Reb-A 97 ()
Reb A ()
Stevioside A3 ()
Glycoside A3 ()
Reb A, Glycoside A3, Stevioside A3 ()
P&D ID
PD060343
CAS
58543-16-1
Tags
available
drug candidate
Drug Status
investigational
Probe control
Probe control not defined
Orthogonal probes
0
No orthogonal probes found
Similar probes
0
No structurally similar probes found
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION
Rebaudioside A is a steviol glycoside and ¦Á-glucosidase inhibitor with an IC50 of 35.01 ug/mL.
DESCRIPTION
Rebaudioside A (Reb A) is a novel agent of glycoside clathration of pharmacons, acts as α-glucosidase inhibitor.
(TargetMol Bioactive Compound Library)
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
Compound Sets
6
Cayman Chemical Bioactives
DrugBank
Enamine Bioactive Compounds
MedChem Express Bioactive Compound Library
Selleckchem Bioactive Compound Library
TargetMol Bioactive Compound Library
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
28
Molecular Weight
966.43
Hydrogen Bond Acceptors
23
Hydrogen Bond Donors
14
Rotatable Bonds
12
Ring Count
8
Aromatic Ring Count
0
cLogP
-5.11
TPSA
374.13
Fraction CSP3
0.93
Chiral centers
26.0
Largest ring
6.0
QED
0.05
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
Target
Fatty Acid Synthase (FASN)
Glycosidase
HMG-CoA Reductase (HMGCR)
LDLR
Endogenous Metabolite
α-glucosidase
Carbohydrate Metabolism
Pathway
Metabolism
Metabolic Enzyme/Protease
Source data

